Coronavirus Update: Lilly Begins Clinical Trial Of Antibody Therapy

Plus News From Resverlogix, Sun And Syntekabio

02 Jun 2020

• By Scrip Team

Discovered at record-breaking speed by AbCellera, Lilly says the antibody candidate could progress into Phase II trials by June.

New_Delhi_Train — New Delhi: Trains and other aspects of life in India have resumed after more than two months of lockdown, despite COVID-19 cases continuing to surge in the country.

More from COVID-19

More from Scrip